FDA Drugs recall ·

Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg… recall

Recall number
D-0102-2025
Date
(initiated November 14, 2024)
Company / brand
Zydus Pharmaceuticals (USA) Inc
73 Route 31 N, Pennington, NJ, United States
Category
Drugs › Class III
Classification
Class III
Status
Ongoing
Units affected
4404 packs
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94. Packaged in sachets

Why was it recalled?

Labeling: Not Elsewhere Classified - Wrong NDC number

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot#: M408002, Exp 05/31/2026

Distribution

USA Nationwide.

What does Class III mean?

Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).

Source: FDA (drugs), recall D-0102-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.